Global Human Varicella-Zoster Immunoglobulin Supply, Demand and Key Producers, 2023-2029
The global Human Varicella-Zoster Immunoglobulin market size is expected to reach $ 204 million by 2029, rising at a market growth of 3.2% CAGR during the forecast period (2023-2029).
Herpes zoster is an acute herpetic viral skin disease caused by the varicella-zoster virus that involves the nerves and skin. Infected individuals treated with human water were less likely to develop severe varicella-zoster virus than those not treated with it.
Human varicella-zoster immune globulin is a solution of antibodies used for post exposure prophylaxis of varicella infections in high risk populations, as well as to reduce the severity of infections.
This report studies the global Human Varicella-Zoster Immunoglobulin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Varicella-Zoster Immunoglobulin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Varicella-Zoster Immunoglobulin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Varicella-Zoster Immunoglobulin total production and demand, 2018-2029, (K Units)
Global Human Varicella-Zoster Immunoglobulin total production value, 2018-2029, (USD Million)
Global Human Varicella-Zoster Immunoglobulin production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Varicella-Zoster Immunoglobulin consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Human Varicella-Zoster Immunoglobulin domestic production, consumption, key domestic manufacturers and share
Global Human Varicella-Zoster Immunoglobulin production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Human Varicella-Zoster Immunoglobulin production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Varicella-Zoster Immunoglobulin production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Human Varicella-Zoster Immunoglobulin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio Products Laboratory, MassBiologics, Saol Therapeutics, Aptevo Biotherapeutics Llc, Ki Biopharma Llc, Cangene Biopharma, Kamada and Salmedon, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Varicella-Zoster Immunoglobulin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Human Varicella-Zoster Immunoglobulin Market, By Region:
1. How big is the global Human Varicella-Zoster Immunoglobulin market?
2. What is the demand of the global Human Varicella-Zoster Immunoglobulin market?
3. What is the year over year growth of the global Human Varicella-Zoster Immunoglobulin market?
4. What is the production and production value of the global Human Varicella-Zoster Immunoglobulin market?
5. Who are the key producers in the global Human Varicella-Zoster Immunoglobulin market?
6. What are the growth factors driving the market demand?
Herpes zoster is an acute herpetic viral skin disease caused by the varicella-zoster virus that involves the nerves and skin. Infected individuals treated with human water were less likely to develop severe varicella-zoster virus than those not treated with it.
Human varicella-zoster immune globulin is a solution of antibodies used for post exposure prophylaxis of varicella infections in high risk populations, as well as to reduce the severity of infections.
This report studies the global Human Varicella-Zoster Immunoglobulin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Varicella-Zoster Immunoglobulin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Varicella-Zoster Immunoglobulin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Varicella-Zoster Immunoglobulin total production and demand, 2018-2029, (K Units)
Global Human Varicella-Zoster Immunoglobulin total production value, 2018-2029, (USD Million)
Global Human Varicella-Zoster Immunoglobulin production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Varicella-Zoster Immunoglobulin consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Human Varicella-Zoster Immunoglobulin domestic production, consumption, key domestic manufacturers and share
Global Human Varicella-Zoster Immunoglobulin production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Human Varicella-Zoster Immunoglobulin production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Varicella-Zoster Immunoglobulin production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Human Varicella-Zoster Immunoglobulin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio Products Laboratory, MassBiologics, Saol Therapeutics, Aptevo Biotherapeutics Llc, Ki Biopharma Llc, Cangene Biopharma, Kamada and Salmedon, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Varicella-Zoster Immunoglobulin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Human Varicella-Zoster Immunoglobulin Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Freeze-dried Powder
- Injection
- Hospital
- Clinic
- Bio Products Laboratory
- MassBiologics
- Saol Therapeutics
- Aptevo Biotherapeutics Llc
- Ki Biopharma Llc
- Cangene Biopharma
- Kamada
- Salmedon
1. How big is the global Human Varicella-Zoster Immunoglobulin market?
2. What is the demand of the global Human Varicella-Zoster Immunoglobulin market?
3. What is the year over year growth of the global Human Varicella-Zoster Immunoglobulin market?
4. What is the production and production value of the global Human Varicella-Zoster Immunoglobulin market?
5. Who are the key producers in the global Human Varicella-Zoster Immunoglobulin market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Human Varicella-Zoster Immunoglobulin Introduction
1.2 World Human Varicella-Zoster Immunoglobulin Supply & Forecast
1.2.1 World Human Varicella-Zoster Immunoglobulin Production Value (2018 & 2022 & 2029)
1.2.2 World Human Varicella-Zoster Immunoglobulin Production (2018-2029)
1.2.3 World Human Varicella-Zoster Immunoglobulin Pricing Trends (2018-2029)
1.3 World Human Varicella-Zoster Immunoglobulin Production by Region (Based on Production Site)
1.3.1 World Human Varicella-Zoster Immunoglobulin Production Value by Region (2018-2029)
1.3.2 World Human Varicella-Zoster Immunoglobulin Production by Region (2018-2029)
1.3.3 World Human Varicella-Zoster Immunoglobulin Average Price by Region (2018-2029)
1.3.4 North America Human Varicella-Zoster Immunoglobulin Production (2018-2029)
1.3.5 Europe Human Varicella-Zoster Immunoglobulin Production (2018-2029)
1.3.6 China Human Varicella-Zoster Immunoglobulin Production (2018-2029)
1.3.7 Japan Human Varicella-Zoster Immunoglobulin Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Varicella-Zoster Immunoglobulin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Varicella-Zoster Immunoglobulin Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Human Varicella-Zoster Immunoglobulin Demand (2018-2029)
2.2 World Human Varicella-Zoster Immunoglobulin Consumption by Region
2.2.1 World Human Varicella-Zoster Immunoglobulin Consumption by Region (2018-2023)
2.2.2 World Human Varicella-Zoster Immunoglobulin Consumption Forecast by Region (2024-2029)
2.3 United States Human Varicella-Zoster Immunoglobulin Consumption (2018-2029)
2.4 China Human Varicella-Zoster Immunoglobulin Consumption (2018-2029)
2.5 Europe Human Varicella-Zoster Immunoglobulin Consumption (2018-2029)
2.6 Japan Human Varicella-Zoster Immunoglobulin Consumption (2018-2029)
2.7 South Korea Human Varicella-Zoster Immunoglobulin Consumption (2018-2029)
2.8 ASEAN Human Varicella-Zoster Immunoglobulin Consumption (2018-2029)
2.9 India Human Varicella-Zoster Immunoglobulin Consumption (2018-2029)
3 WORLD HUMAN VARICELLA-ZOSTER IMMUNOGLOBULIN MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Human Varicella-Zoster Immunoglobulin Production Value by Manufacturer (2018-2023)
3.2 World Human Varicella-Zoster Immunoglobulin Production by Manufacturer (2018-2023)
3.3 World Human Varicella-Zoster Immunoglobulin Average Price by Manufacturer (2018-2023)
3.4 Human Varicella-Zoster Immunoglobulin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Human Varicella-Zoster Immunoglobulin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Human Varicella-Zoster Immunoglobulin in 2022
3.5.3 Global Concentration Ratios (CR8) for Human Varicella-Zoster Immunoglobulin in 2022
3.6 Human Varicella-Zoster Immunoglobulin Market: Overall Company Footprint Analysis
3.6.1 Human Varicella-Zoster Immunoglobulin Market: Region Footprint
3.6.2 Human Varicella-Zoster Immunoglobulin Market: Company Product Type Footprint
3.6.3 Human Varicella-Zoster Immunoglobulin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Human Varicella-Zoster Immunoglobulin Production Value Comparison
4.1.1 United States VS China: Human Varicella-Zoster Immunoglobulin Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Human Varicella-Zoster Immunoglobulin Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Human Varicella-Zoster Immunoglobulin Production Comparison
4.2.1 United States VS China: Human Varicella-Zoster Immunoglobulin Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Human Varicella-Zoster Immunoglobulin Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Human Varicella-Zoster Immunoglobulin Consumption Comparison
4.3.1 United States VS China: Human Varicella-Zoster Immunoglobulin Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Human Varicella-Zoster Immunoglobulin Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Human Varicella-Zoster Immunoglobulin Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Human Varicella-Zoster Immunoglobulin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value (2018-2023)
4.4.3 United States Based Manufacturers Human Varicella-Zoster Immunoglobulin Production (2018-2023)
4.5 China Based Human Varicella-Zoster Immunoglobulin Manufacturers and Market Share
4.5.1 China Based Human Varicella-Zoster Immunoglobulin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value (2018-2023)
4.5.3 China Based Manufacturers Human Varicella-Zoster Immunoglobulin Production (2018-2023)
4.6 Rest of World Based Human Varicella-Zoster Immunoglobulin Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Human Varicella-Zoster Immunoglobulin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Human Varicella-Zoster Immunoglobulin Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Varicella-Zoster Immunoglobulin Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Freeze-dried Powder
5.2.2 Injection
5.3 Market Segment by Type
5.3.1 World Human Varicella-Zoster Immunoglobulin Production by Type (2018-2029)
5.3.2 World Human Varicella-Zoster Immunoglobulin Production Value by Type (2018-2029)
5.3.3 World Human Varicella-Zoster Immunoglobulin Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Varicella-Zoster Immunoglobulin Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Human Varicella-Zoster Immunoglobulin Production by Application (2018-2029)
6.3.2 World Human Varicella-Zoster Immunoglobulin Production Value by Application (2018-2029)
6.3.3 World Human Varicella-Zoster Immunoglobulin Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Bio Products Laboratory
7.1.1 Bio Products Laboratory Details
7.1.2 Bio Products Laboratory Major Business
7.1.3 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Product and Services
7.1.4 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bio Products Laboratory Recent Developments/Updates
7.1.6 Bio Products Laboratory Competitive Strengths & Weaknesses
7.2 MassBiologics
7.2.1 MassBiologics Details
7.2.2 MassBiologics Major Business
7.2.3 MassBiologics Human Varicella-Zoster Immunoglobulin Product and Services
7.2.4 MassBiologics Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 MassBiologics Recent Developments/Updates
7.2.6 MassBiologics Competitive Strengths & Weaknesses
7.3 Saol Therapeutics
7.3.1 Saol Therapeutics Details
7.3.2 Saol Therapeutics Major Business
7.3.3 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Product and Services
7.3.4 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Saol Therapeutics Recent Developments/Updates
7.3.6 Saol Therapeutics Competitive Strengths & Weaknesses
7.4 Aptevo Biotherapeutics Llc
7.4.1 Aptevo Biotherapeutics Llc Details
7.4.2 Aptevo Biotherapeutics Llc Major Business
7.4.3 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Product and Services
7.4.4 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Aptevo Biotherapeutics Llc Recent Developments/Updates
7.4.6 Aptevo Biotherapeutics Llc Competitive Strengths & Weaknesses
7.5 Ki Biopharma Llc
7.5.1 Ki Biopharma Llc Details
7.5.2 Ki Biopharma Llc Major Business
7.5.3 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Product and Services
7.5.4 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Ki Biopharma Llc Recent Developments/Updates
7.5.6 Ki Biopharma Llc Competitive Strengths & Weaknesses
7.6 Cangene Biopharma
7.6.1 Cangene Biopharma Details
7.6.2 Cangene Biopharma Major Business
7.6.3 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Product and Services
7.6.4 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Cangene Biopharma Recent Developments/Updates
7.6.6 Cangene Biopharma Competitive Strengths & Weaknesses
7.7 Kamada
7.7.1 Kamada Details
7.7.2 Kamada Major Business
7.7.3 Kamada Human Varicella-Zoster Immunoglobulin Product and Services
7.7.4 Kamada Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Kamada Recent Developments/Updates
7.7.6 Kamada Competitive Strengths & Weaknesses
7.8 Salmedon
7.8.1 Salmedon Details
7.8.2 Salmedon Major Business
7.8.3 Salmedon Human Varicella-Zoster Immunoglobulin Product and Services
7.8.4 Salmedon Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Salmedon Recent Developments/Updates
7.8.6 Salmedon Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Varicella-Zoster Immunoglobulin Industry Chain
8.2 Human Varicella-Zoster Immunoglobulin Upstream Analysis
8.2.1 Human Varicella-Zoster Immunoglobulin Core Raw Materials
8.2.2 Main Manufacturers of Human Varicella-Zoster Immunoglobulin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Human Varicella-Zoster Immunoglobulin Production Mode
8.6 Human Varicella-Zoster Immunoglobulin Procurement Model
8.7 Human Varicella-Zoster Immunoglobulin Industry Sales Model and Sales Channels
8.7.1 Human Varicella-Zoster Immunoglobulin Sales Model
8.7.2 Human Varicella-Zoster Immunoglobulin Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Human Varicella-Zoster Immunoglobulin Introduction
1.2 World Human Varicella-Zoster Immunoglobulin Supply & Forecast
1.2.1 World Human Varicella-Zoster Immunoglobulin Production Value (2018 & 2022 & 2029)
1.2.2 World Human Varicella-Zoster Immunoglobulin Production (2018-2029)
1.2.3 World Human Varicella-Zoster Immunoglobulin Pricing Trends (2018-2029)
1.3 World Human Varicella-Zoster Immunoglobulin Production by Region (Based on Production Site)
1.3.1 World Human Varicella-Zoster Immunoglobulin Production Value by Region (2018-2029)
1.3.2 World Human Varicella-Zoster Immunoglobulin Production by Region (2018-2029)
1.3.3 World Human Varicella-Zoster Immunoglobulin Average Price by Region (2018-2029)
1.3.4 North America Human Varicella-Zoster Immunoglobulin Production (2018-2029)
1.3.5 Europe Human Varicella-Zoster Immunoglobulin Production (2018-2029)
1.3.6 China Human Varicella-Zoster Immunoglobulin Production (2018-2029)
1.3.7 Japan Human Varicella-Zoster Immunoglobulin Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Varicella-Zoster Immunoglobulin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Varicella-Zoster Immunoglobulin Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Human Varicella-Zoster Immunoglobulin Demand (2018-2029)
2.2 World Human Varicella-Zoster Immunoglobulin Consumption by Region
2.2.1 World Human Varicella-Zoster Immunoglobulin Consumption by Region (2018-2023)
2.2.2 World Human Varicella-Zoster Immunoglobulin Consumption Forecast by Region (2024-2029)
2.3 United States Human Varicella-Zoster Immunoglobulin Consumption (2018-2029)
2.4 China Human Varicella-Zoster Immunoglobulin Consumption (2018-2029)
2.5 Europe Human Varicella-Zoster Immunoglobulin Consumption (2018-2029)
2.6 Japan Human Varicella-Zoster Immunoglobulin Consumption (2018-2029)
2.7 South Korea Human Varicella-Zoster Immunoglobulin Consumption (2018-2029)
2.8 ASEAN Human Varicella-Zoster Immunoglobulin Consumption (2018-2029)
2.9 India Human Varicella-Zoster Immunoglobulin Consumption (2018-2029)
3 WORLD HUMAN VARICELLA-ZOSTER IMMUNOGLOBULIN MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Human Varicella-Zoster Immunoglobulin Production Value by Manufacturer (2018-2023)
3.2 World Human Varicella-Zoster Immunoglobulin Production by Manufacturer (2018-2023)
3.3 World Human Varicella-Zoster Immunoglobulin Average Price by Manufacturer (2018-2023)
3.4 Human Varicella-Zoster Immunoglobulin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Human Varicella-Zoster Immunoglobulin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Human Varicella-Zoster Immunoglobulin in 2022
3.5.3 Global Concentration Ratios (CR8) for Human Varicella-Zoster Immunoglobulin in 2022
3.6 Human Varicella-Zoster Immunoglobulin Market: Overall Company Footprint Analysis
3.6.1 Human Varicella-Zoster Immunoglobulin Market: Region Footprint
3.6.2 Human Varicella-Zoster Immunoglobulin Market: Company Product Type Footprint
3.6.3 Human Varicella-Zoster Immunoglobulin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Human Varicella-Zoster Immunoglobulin Production Value Comparison
4.1.1 United States VS China: Human Varicella-Zoster Immunoglobulin Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Human Varicella-Zoster Immunoglobulin Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Human Varicella-Zoster Immunoglobulin Production Comparison
4.2.1 United States VS China: Human Varicella-Zoster Immunoglobulin Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Human Varicella-Zoster Immunoglobulin Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Human Varicella-Zoster Immunoglobulin Consumption Comparison
4.3.1 United States VS China: Human Varicella-Zoster Immunoglobulin Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Human Varicella-Zoster Immunoglobulin Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Human Varicella-Zoster Immunoglobulin Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Human Varicella-Zoster Immunoglobulin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value (2018-2023)
4.4.3 United States Based Manufacturers Human Varicella-Zoster Immunoglobulin Production (2018-2023)
4.5 China Based Human Varicella-Zoster Immunoglobulin Manufacturers and Market Share
4.5.1 China Based Human Varicella-Zoster Immunoglobulin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value (2018-2023)
4.5.3 China Based Manufacturers Human Varicella-Zoster Immunoglobulin Production (2018-2023)
4.6 Rest of World Based Human Varicella-Zoster Immunoglobulin Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Human Varicella-Zoster Immunoglobulin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Human Varicella-Zoster Immunoglobulin Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Varicella-Zoster Immunoglobulin Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Freeze-dried Powder
5.2.2 Injection
5.3 Market Segment by Type
5.3.1 World Human Varicella-Zoster Immunoglobulin Production by Type (2018-2029)
5.3.2 World Human Varicella-Zoster Immunoglobulin Production Value by Type (2018-2029)
5.3.3 World Human Varicella-Zoster Immunoglobulin Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Varicella-Zoster Immunoglobulin Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Human Varicella-Zoster Immunoglobulin Production by Application (2018-2029)
6.3.2 World Human Varicella-Zoster Immunoglobulin Production Value by Application (2018-2029)
6.3.3 World Human Varicella-Zoster Immunoglobulin Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Bio Products Laboratory
7.1.1 Bio Products Laboratory Details
7.1.2 Bio Products Laboratory Major Business
7.1.3 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Product and Services
7.1.4 Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bio Products Laboratory Recent Developments/Updates
7.1.6 Bio Products Laboratory Competitive Strengths & Weaknesses
7.2 MassBiologics
7.2.1 MassBiologics Details
7.2.2 MassBiologics Major Business
7.2.3 MassBiologics Human Varicella-Zoster Immunoglobulin Product and Services
7.2.4 MassBiologics Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 MassBiologics Recent Developments/Updates
7.2.6 MassBiologics Competitive Strengths & Weaknesses
7.3 Saol Therapeutics
7.3.1 Saol Therapeutics Details
7.3.2 Saol Therapeutics Major Business
7.3.3 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Product and Services
7.3.4 Saol Therapeutics Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Saol Therapeutics Recent Developments/Updates
7.3.6 Saol Therapeutics Competitive Strengths & Weaknesses
7.4 Aptevo Biotherapeutics Llc
7.4.1 Aptevo Biotherapeutics Llc Details
7.4.2 Aptevo Biotherapeutics Llc Major Business
7.4.3 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Product and Services
7.4.4 Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Aptevo Biotherapeutics Llc Recent Developments/Updates
7.4.6 Aptevo Biotherapeutics Llc Competitive Strengths & Weaknesses
7.5 Ki Biopharma Llc
7.5.1 Ki Biopharma Llc Details
7.5.2 Ki Biopharma Llc Major Business
7.5.3 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Product and Services
7.5.4 Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Ki Biopharma Llc Recent Developments/Updates
7.5.6 Ki Biopharma Llc Competitive Strengths & Weaknesses
7.6 Cangene Biopharma
7.6.1 Cangene Biopharma Details
7.6.2 Cangene Biopharma Major Business
7.6.3 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Product and Services
7.6.4 Cangene Biopharma Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Cangene Biopharma Recent Developments/Updates
7.6.6 Cangene Biopharma Competitive Strengths & Weaknesses
7.7 Kamada
7.7.1 Kamada Details
7.7.2 Kamada Major Business
7.7.3 Kamada Human Varicella-Zoster Immunoglobulin Product and Services
7.7.4 Kamada Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Kamada Recent Developments/Updates
7.7.6 Kamada Competitive Strengths & Weaknesses
7.8 Salmedon
7.8.1 Salmedon Details
7.8.2 Salmedon Major Business
7.8.3 Salmedon Human Varicella-Zoster Immunoglobulin Product and Services
7.8.4 Salmedon Human Varicella-Zoster Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Salmedon Recent Developments/Updates
7.8.6 Salmedon Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Varicella-Zoster Immunoglobulin Industry Chain
8.2 Human Varicella-Zoster Immunoglobulin Upstream Analysis
8.2.1 Human Varicella-Zoster Immunoglobulin Core Raw Materials
8.2.2 Main Manufacturers of Human Varicella-Zoster Immunoglobulin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Human Varicella-Zoster Immunoglobulin Production Mode
8.6 Human Varicella-Zoster Immunoglobulin Procurement Model
8.7 Human Varicella-Zoster Immunoglobulin Industry Sales Model and Sales Channels
8.7.1 Human Varicella-Zoster Immunoglobulin Sales Model
8.7.2 Human Varicella-Zoster Immunoglobulin Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Human Varicella-Zoster Immunoglobulin Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Human Varicella-Zoster Immunoglobulin Production Value by Region (2018-2023) & (USD Million)
Table 3. World Human Varicella-Zoster Immunoglobulin Production Value by Region (2024-2029) & (USD Million)
Table 4. World Human Varicella-Zoster Immunoglobulin Production Value Market Share by Region (2018-2023)
Table 5. World Human Varicella-Zoster Immunoglobulin Production Value Market Share by Region (2024-2029)
Table 6. World Human Varicella-Zoster Immunoglobulin Production by Region (2018-2023) & (K Units)
Table 7. World Human Varicella-Zoster Immunoglobulin Production by Region (2024-2029) & (K Units)
Table 8. World Human Varicella-Zoster Immunoglobulin Production Market Share by Region (2018-2023)
Table 9. World Human Varicella-Zoster Immunoglobulin Production Market Share by Region (2024-2029)
Table 10. World Human Varicella-Zoster Immunoglobulin Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Human Varicella-Zoster Immunoglobulin Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Human Varicella-Zoster Immunoglobulin Major Market Trends
Table 13. World Human Varicella-Zoster Immunoglobulin Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Human Varicella-Zoster Immunoglobulin Consumption by Region (2018-2023) & (K Units)
Table 15. World Human Varicella-Zoster Immunoglobulin Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Human Varicella-Zoster Immunoglobulin Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Human Varicella-Zoster Immunoglobulin Producers in 2022
Table 18. World Human Varicella-Zoster Immunoglobulin Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Human Varicella-Zoster Immunoglobulin Producers in 2022
Table 20. World Human Varicella-Zoster Immunoglobulin Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Human Varicella-Zoster Immunoglobulin Company Evaluation Quadrant
Table 22. World Human Varicella-Zoster Immunoglobulin Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Human Varicella-Zoster Immunoglobulin Production Site of Key Manufacturer
Table 24. Human Varicella-Zoster Immunoglobulin Market: Company Product Type Footprint
Table 25. Human Varicella-Zoster Immunoglobulin Market: Company Product Application Footprint
Table 26. Human Varicella-Zoster Immunoglobulin Competitive Factors
Table 27. Human Varicella-Zoster Immunoglobulin New Entrant and Capacity Expansion Plans
Table 28. Human Varicella-Zoster Immunoglobulin Mergers & Acquisitions Activity
Table 29. United States VS China Human Varicella-Zoster Immunoglobulin Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Human Varicella-Zoster Immunoglobulin Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Human Varicella-Zoster Immunoglobulin Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Human Varicella-Zoster Immunoglobulin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Human Varicella-Zoster Immunoglobulin Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Market Share (2018-2023)
Table 37. China Based Human Varicella-Zoster Immunoglobulin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Human Varicella-Zoster Immunoglobulin Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Market Share (2018-2023)
Table 42. Rest of World Based Human Varicella-Zoster Immunoglobulin Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Human Varicella-Zoster Immunoglobulin Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Market Share (2018-2023)
Table 47. World Human Varicella-Zoster Immunoglobulin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Human Varicella-Zoster Immunoglobulin Production by Type (2018-2023) & (K Units)
Table 49. World Human Varicella-Zoster Immunoglobulin Production by Type (2024-2029) & (K Units)
Table 50. World Human Varicella-Zoster Immunoglobulin Production Value by Type (2018-2023) & (USD Million)
Table 51. World Human Varicella-Zoster Immunoglobulin Production Value by Type (2024-2029) & (USD Million)
Table 52. World Human Varicella-Zoster Immunoglobulin Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Human Varicella-Zoster Immunoglobulin Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Human Varicella-Zoster Immunoglobulin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Human Varicella-Zoster Immunoglobulin Production by Application (2018-2023) & (K Units)
Table 56. World Human Varicella-Zoster Immunoglobulin Production by Application (2024-2029) & (K Units)
Table 57. World Human Varicella-Zoster Immunoglobulin Production Value by Application (2018-2023) & (USD Million)
Table 58. World Human Varicella-Zoster Immunoglobulin Production Value by Application (2024-2029) & (USD Million)
Table 59. World Human Varicella-Zoster Immunoglobulin Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Human Varicella-Zoster Immunoglobulin Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Bio Products Laboratory Basic Information, Manufacturing Base and Competitors
Table 62. Bio Products Laboratory Major Business
Table 63. Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Product and Services
Table 64. Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bio Products Laboratory Recent Developments/Updates
Table 66. Bio Products Laboratory Competitive Strengths & Weaknesses
Table 67. MassBiologics Basic Information, Manufacturing Base and Competitors
Table 68. MassBiologics Major Business
Table 69. MassBiologics Human Varicella-Zoster Immunoglobulin Product and Services
Table 70. MassBiologics Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. MassBiologics Recent Developments/Updates
Table 72. MassBiologics Competitive Strengths & Weaknesses
Table 73. Saol Therapeutics Basic Information, Manufacturing Base and Competitors
Table 74. Saol Therapeutics Major Business
Table 75. Saol Therapeutics Human Varicella-Zoster Immunoglobulin Product and Services
Table 76. Saol Therapeutics Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Saol Therapeutics Recent Developments/Updates
Table 78. Saol Therapeutics Competitive Strengths & Weaknesses
Table 79. Aptevo Biotherapeutics Llc Basic Information, Manufacturing Base and Competitors
Table 80. Aptevo Biotherapeutics Llc Major Business
Table 81. Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Product and Services
Table 82. Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Aptevo Biotherapeutics Llc Recent Developments/Updates
Table 84. Aptevo Biotherapeutics Llc Competitive Strengths & Weaknesses
Table 85. Ki Biopharma Llc Basic Information, Manufacturing Base and Competitors
Table 86. Ki Biopharma Llc Major Business
Table 87. Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Product and Services
Table 88. Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Ki Biopharma Llc Recent Developments/Updates
Table 90. Ki Biopharma Llc Competitive Strengths & Weaknesses
Table 91. Cangene Biopharma Basic Information, Manufacturing Base and Competitors
Table 92. Cangene Biopharma Major Business
Table 93. Cangene Biopharma Human Varicella-Zoster Immunoglobulin Product and Services
Table 94. Cangene Biopharma Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Cangene Biopharma Recent Developments/Updates
Table 96. Cangene Biopharma Competitive Strengths & Weaknesses
Table 97. Kamada Basic Information, Manufacturing Base and Competitors
Table 98. Kamada Major Business
Table 99. Kamada Human Varicella-Zoster Immunoglobulin Product and Services
Table 100. Kamada Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Kamada Recent Developments/Updates
Table 102. Salmedon Basic Information, Manufacturing Base and Competitors
Table 103. Salmedon Major Business
Table 104. Salmedon Human Varicella-Zoster Immunoglobulin Product and Services
Table 105. Salmedon Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 106. Global Key Players of Human Varicella-Zoster Immunoglobulin Upstream (Raw Materials)
Table 107. Human Varicella-Zoster Immunoglobulin Typical Customers
Table 108. Human Varicella-Zoster Immunoglobulin Typical Distributors
Table 1. World Human Varicella-Zoster Immunoglobulin Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Human Varicella-Zoster Immunoglobulin Production Value by Region (2018-2023) & (USD Million)
Table 3. World Human Varicella-Zoster Immunoglobulin Production Value by Region (2024-2029) & (USD Million)
Table 4. World Human Varicella-Zoster Immunoglobulin Production Value Market Share by Region (2018-2023)
Table 5. World Human Varicella-Zoster Immunoglobulin Production Value Market Share by Region (2024-2029)
Table 6. World Human Varicella-Zoster Immunoglobulin Production by Region (2018-2023) & (K Units)
Table 7. World Human Varicella-Zoster Immunoglobulin Production by Region (2024-2029) & (K Units)
Table 8. World Human Varicella-Zoster Immunoglobulin Production Market Share by Region (2018-2023)
Table 9. World Human Varicella-Zoster Immunoglobulin Production Market Share by Region (2024-2029)
Table 10. World Human Varicella-Zoster Immunoglobulin Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Human Varicella-Zoster Immunoglobulin Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Human Varicella-Zoster Immunoglobulin Major Market Trends
Table 13. World Human Varicella-Zoster Immunoglobulin Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Human Varicella-Zoster Immunoglobulin Consumption by Region (2018-2023) & (K Units)
Table 15. World Human Varicella-Zoster Immunoglobulin Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Human Varicella-Zoster Immunoglobulin Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Human Varicella-Zoster Immunoglobulin Producers in 2022
Table 18. World Human Varicella-Zoster Immunoglobulin Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Human Varicella-Zoster Immunoglobulin Producers in 2022
Table 20. World Human Varicella-Zoster Immunoglobulin Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Human Varicella-Zoster Immunoglobulin Company Evaluation Quadrant
Table 22. World Human Varicella-Zoster Immunoglobulin Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Human Varicella-Zoster Immunoglobulin Production Site of Key Manufacturer
Table 24. Human Varicella-Zoster Immunoglobulin Market: Company Product Type Footprint
Table 25. Human Varicella-Zoster Immunoglobulin Market: Company Product Application Footprint
Table 26. Human Varicella-Zoster Immunoglobulin Competitive Factors
Table 27. Human Varicella-Zoster Immunoglobulin New Entrant and Capacity Expansion Plans
Table 28. Human Varicella-Zoster Immunoglobulin Mergers & Acquisitions Activity
Table 29. United States VS China Human Varicella-Zoster Immunoglobulin Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Human Varicella-Zoster Immunoglobulin Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Human Varicella-Zoster Immunoglobulin Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Human Varicella-Zoster Immunoglobulin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Human Varicella-Zoster Immunoglobulin Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Market Share (2018-2023)
Table 37. China Based Human Varicella-Zoster Immunoglobulin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Human Varicella-Zoster Immunoglobulin Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Market Share (2018-2023)
Table 42. Rest of World Based Human Varicella-Zoster Immunoglobulin Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Human Varicella-Zoster Immunoglobulin Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Market Share (2018-2023)
Table 47. World Human Varicella-Zoster Immunoglobulin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Human Varicella-Zoster Immunoglobulin Production by Type (2018-2023) & (K Units)
Table 49. World Human Varicella-Zoster Immunoglobulin Production by Type (2024-2029) & (K Units)
Table 50. World Human Varicella-Zoster Immunoglobulin Production Value by Type (2018-2023) & (USD Million)
Table 51. World Human Varicella-Zoster Immunoglobulin Production Value by Type (2024-2029) & (USD Million)
Table 52. World Human Varicella-Zoster Immunoglobulin Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Human Varicella-Zoster Immunoglobulin Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Human Varicella-Zoster Immunoglobulin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Human Varicella-Zoster Immunoglobulin Production by Application (2018-2023) & (K Units)
Table 56. World Human Varicella-Zoster Immunoglobulin Production by Application (2024-2029) & (K Units)
Table 57. World Human Varicella-Zoster Immunoglobulin Production Value by Application (2018-2023) & (USD Million)
Table 58. World Human Varicella-Zoster Immunoglobulin Production Value by Application (2024-2029) & (USD Million)
Table 59. World Human Varicella-Zoster Immunoglobulin Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Human Varicella-Zoster Immunoglobulin Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Bio Products Laboratory Basic Information, Manufacturing Base and Competitors
Table 62. Bio Products Laboratory Major Business
Table 63. Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Product and Services
Table 64. Bio Products Laboratory Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bio Products Laboratory Recent Developments/Updates
Table 66. Bio Products Laboratory Competitive Strengths & Weaknesses
Table 67. MassBiologics Basic Information, Manufacturing Base and Competitors
Table 68. MassBiologics Major Business
Table 69. MassBiologics Human Varicella-Zoster Immunoglobulin Product and Services
Table 70. MassBiologics Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. MassBiologics Recent Developments/Updates
Table 72. MassBiologics Competitive Strengths & Weaknesses
Table 73. Saol Therapeutics Basic Information, Manufacturing Base and Competitors
Table 74. Saol Therapeutics Major Business
Table 75. Saol Therapeutics Human Varicella-Zoster Immunoglobulin Product and Services
Table 76. Saol Therapeutics Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Saol Therapeutics Recent Developments/Updates
Table 78. Saol Therapeutics Competitive Strengths & Weaknesses
Table 79. Aptevo Biotherapeutics Llc Basic Information, Manufacturing Base and Competitors
Table 80. Aptevo Biotherapeutics Llc Major Business
Table 81. Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Product and Services
Table 82. Aptevo Biotherapeutics Llc Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Aptevo Biotherapeutics Llc Recent Developments/Updates
Table 84. Aptevo Biotherapeutics Llc Competitive Strengths & Weaknesses
Table 85. Ki Biopharma Llc Basic Information, Manufacturing Base and Competitors
Table 86. Ki Biopharma Llc Major Business
Table 87. Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Product and Services
Table 88. Ki Biopharma Llc Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Ki Biopharma Llc Recent Developments/Updates
Table 90. Ki Biopharma Llc Competitive Strengths & Weaknesses
Table 91. Cangene Biopharma Basic Information, Manufacturing Base and Competitors
Table 92. Cangene Biopharma Major Business
Table 93. Cangene Biopharma Human Varicella-Zoster Immunoglobulin Product and Services
Table 94. Cangene Biopharma Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Cangene Biopharma Recent Developments/Updates
Table 96. Cangene Biopharma Competitive Strengths & Weaknesses
Table 97. Kamada Basic Information, Manufacturing Base and Competitors
Table 98. Kamada Major Business
Table 99. Kamada Human Varicella-Zoster Immunoglobulin Product and Services
Table 100. Kamada Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Kamada Recent Developments/Updates
Table 102. Salmedon Basic Information, Manufacturing Base and Competitors
Table 103. Salmedon Major Business
Table 104. Salmedon Human Varicella-Zoster Immunoglobulin Product and Services
Table 105. Salmedon Human Varicella-Zoster Immunoglobulin Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 106. Global Key Players of Human Varicella-Zoster Immunoglobulin Upstream (Raw Materials)
Table 107. Human Varicella-Zoster Immunoglobulin Typical Customers
Table 108. Human Varicella-Zoster Immunoglobulin Typical Distributors
LIST OF FIGURES
Figure 1. Human Varicella-Zoster Immunoglobulin Picture
Figure 2. World Human Varicella-Zoster Immunoglobulin Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Human Varicella-Zoster Immunoglobulin Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Human Varicella-Zoster Immunoglobulin Production (2018-2029) & (K Units)
Figure 5. World Human Varicella-Zoster Immunoglobulin Average Price (2018-2029) & (US$/Unit)
Figure 6. World Human Varicella-Zoster Immunoglobulin Production Value Market Share by Region (2018-2029)
Figure 7. World Human Varicella-Zoster Immunoglobulin Production Market Share by Region (2018-2029)
Figure 8. North America Human Varicella-Zoster Immunoglobulin Production (2018-2029) & (K Units)
Figure 9. Europe Human Varicella-Zoster Immunoglobulin Production (2018-2029) & (K Units)
Figure 10. China Human Varicella-Zoster Immunoglobulin Production (2018-2029) & (K Units)
Figure 11. Japan Human Varicella-Zoster Immunoglobulin Production (2018-2029) & (K Units)
Figure 12. Human Varicella-Zoster Immunoglobulin Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 15. World Human Varicella-Zoster Immunoglobulin Consumption Market Share by Region (2018-2029)
Figure 16. United States Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 17. China Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 18. Europe Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 19. Japan Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 20. South Korea Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 22. India Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Human Varicella-Zoster Immunoglobulin by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Varicella-Zoster Immunoglobulin Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Varicella-Zoster Immunoglobulin Markets in 2022
Figure 26. United States VS China: Human Varicella-Zoster Immunoglobulin Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Human Varicella-Zoster Immunoglobulin Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Human Varicella-Zoster Immunoglobulin Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Market Share 2022
Figure 30. China Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Market Share 2022
Figure 32. World Human Varicella-Zoster Immunoglobulin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Human Varicella-Zoster Immunoglobulin Production Value Market Share by Type in 2022
Figure 34. Freeze-dried Powder
Figure 35. Injection
Figure 36. World Human Varicella-Zoster Immunoglobulin Production Market Share by Type (2018-2029)
Figure 37. World Human Varicella-Zoster Immunoglobulin Production Value Market Share by Type (2018-2029)
Figure 38. World Human Varicella-Zoster Immunoglobulin Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Human Varicella-Zoster Immunoglobulin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Human Varicella-Zoster Immunoglobulin Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Human Varicella-Zoster Immunoglobulin Production Market Share by Application (2018-2029)
Figure 44. World Human Varicella-Zoster Immunoglobulin Production Value Market Share by Application (2018-2029)
Figure 45. World Human Varicella-Zoster Immunoglobulin Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Human Varicella-Zoster Immunoglobulin Industry Chain
Figure 47. Human Varicella-Zoster Immunoglobulin Procurement Model
Figure 48. Human Varicella-Zoster Immunoglobulin Sales Model
Figure 49. Human Varicella-Zoster Immunoglobulin Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Human Varicella-Zoster Immunoglobulin Picture
Figure 2. World Human Varicella-Zoster Immunoglobulin Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Human Varicella-Zoster Immunoglobulin Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Human Varicella-Zoster Immunoglobulin Production (2018-2029) & (K Units)
Figure 5. World Human Varicella-Zoster Immunoglobulin Average Price (2018-2029) & (US$/Unit)
Figure 6. World Human Varicella-Zoster Immunoglobulin Production Value Market Share by Region (2018-2029)
Figure 7. World Human Varicella-Zoster Immunoglobulin Production Market Share by Region (2018-2029)
Figure 8. North America Human Varicella-Zoster Immunoglobulin Production (2018-2029) & (K Units)
Figure 9. Europe Human Varicella-Zoster Immunoglobulin Production (2018-2029) & (K Units)
Figure 10. China Human Varicella-Zoster Immunoglobulin Production (2018-2029) & (K Units)
Figure 11. Japan Human Varicella-Zoster Immunoglobulin Production (2018-2029) & (K Units)
Figure 12. Human Varicella-Zoster Immunoglobulin Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 15. World Human Varicella-Zoster Immunoglobulin Consumption Market Share by Region (2018-2029)
Figure 16. United States Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 17. China Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 18. Europe Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 19. Japan Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 20. South Korea Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 22. India Human Varicella-Zoster Immunoglobulin Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Human Varicella-Zoster Immunoglobulin by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Varicella-Zoster Immunoglobulin Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Varicella-Zoster Immunoglobulin Markets in 2022
Figure 26. United States VS China: Human Varicella-Zoster Immunoglobulin Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Human Varicella-Zoster Immunoglobulin Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Human Varicella-Zoster Immunoglobulin Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Market Share 2022
Figure 30. China Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Human Varicella-Zoster Immunoglobulin Production Market Share 2022
Figure 32. World Human Varicella-Zoster Immunoglobulin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Human Varicella-Zoster Immunoglobulin Production Value Market Share by Type in 2022
Figure 34. Freeze-dried Powder
Figure 35. Injection
Figure 36. World Human Varicella-Zoster Immunoglobulin Production Market Share by Type (2018-2029)
Figure 37. World Human Varicella-Zoster Immunoglobulin Production Value Market Share by Type (2018-2029)
Figure 38. World Human Varicella-Zoster Immunoglobulin Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Human Varicella-Zoster Immunoglobulin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Human Varicella-Zoster Immunoglobulin Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Human Varicella-Zoster Immunoglobulin Production Market Share by Application (2018-2029)
Figure 44. World Human Varicella-Zoster Immunoglobulin Production Value Market Share by Application (2018-2029)
Figure 45. World Human Varicella-Zoster Immunoglobulin Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Human Varicella-Zoster Immunoglobulin Industry Chain
Figure 47. Human Varicella-Zoster Immunoglobulin Procurement Model
Figure 48. Human Varicella-Zoster Immunoglobulin Sales Model
Figure 49. Human Varicella-Zoster Immunoglobulin Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
